{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:08:26Z","timestamp":1791223706475,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND:<\/jats:bold>\n                    Uridine diphosphate (UDP) is an extracellular nucleotide signaling molecule implicated in diverse biological processes via specific activation of pyrimidinergic receptor P2Y, G Protein-Coupled, 6 (P2Y6). There is very little knowledge about the function and mechanism of UDP in rheumatoid arthritis (RA).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>METHODS:<\/jats:bold>\n                    This study used a quasi-targeted liquid chromatography-mass spectrometry (LC-MS) approach to investigate the unique expression of metabolites in RA synovial fluids (SF) (\n                    <jats:italic>n<\/jats:italic>\n                    = 10) with samples from osteoarthritis (OA) as controls (\n                    <jats:italic>n<\/jats:italic>\n                    = 10). RA fibroblast-like synoviocytes (FLSs) were collected from synovial tissues (\n                    <jats:italic>n<\/jats:italic>\n                    = 5) and cultured with UDP or MRS2578, a P2Y6 antagonist, and FLSs from OA were used as controls (\n                    <jats:italic>n<\/jats:italic>\n                    = 5). Rats with collagen-induced arthritis (CIA) were injected with UDP, MRS2578 or both (\n                    <jats:italic>n<\/jats:italic>\n                    = 9 for each group). P2Y6 expression was examined using real-time PCR, Western blotting and immunohistochemistry. Cell proliferation, apoptosis and migration of RA FLSs were measured using CCK-8 assay, real-time cell analysis, flow cytometry, wound healing assay and Transwell assay, respectively. The UDP levels in the culture medium, synovial fluid (\n                    <jats:italic>n<\/jats:italic>\n                    = 36) and peripheral blood (\n                    <jats:italic>n<\/jats:italic>\n                    = 36) of RA and CIA rats were measured using a Transcreener UDP Assay. Levels of proinflammatory cytokines were measured using a flow assay. Interleukin-6 (IL-6) levels were measured using ELISA and flow.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    LC-MS analysis detected significantly increased UDP levels in RA SF compared with OA SF, and the level was positively correlated with anticyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF)levels in RA. The increased UDP concentration was verified in the blood and synovial fluids of RA patients compared with samples from OA patients and healthy volunteers, respectively. UDP stimulated cell proliferation, migration and IL-6 secretion in RA FLSs and inhibited their apoptosis in culture, and MRS2578 inhibited these effects of UDP. UDP injection accelerated CIA and stimulated IL-6 production rather than other proinflammatory cytokines in the rat model, but simultaneous injection of MRS2578 suppressed these effects and alleviated CIA. P2Y6 expression was increased in RA and CIA synovial tissues.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    These results suggest that UDP is highly expressed in RA and stimulates RA pathogenesis by promoting P2Y6 activities to increase IL-6 production.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2021.658511","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:23:44Z","timestamp":1618791824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation"],"prefix":"10.3389","volume":"12","author":[{"given":"Hongxing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00296-012-2375-7","article-title":"Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage","volume":"33","author":"Abdel Meguid","year":"2013","journal-title":"Rheumatol. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1749-6632.1998.tb09122.x","article-title":"Developing guidelines on the care and use of animals","volume":"862","author":"Bayne","year":"1998","journal-title":"Ann. NY Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/s-2005-869519","article-title":"Overview of the P2 receptors","volume":"31","author":"Boeynaems","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"B33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: Mode of Action in the Treatment of Rheumatoid Arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Geophys. Monogr. Ser."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1124\/mol.109.058578","article-title":"Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor","volume":"76","author":"Carter","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbrc.2005.03.004","article-title":"The Pyrimidinergic P2Y6 Receptor Mediates a Novel Release of Proinflammatory Cytokines and Chemokines in Monocytic Cells Stimulated with UDP","volume":"330","author":"Cox","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1021\/jm1016297","article-title":"Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6Receptors","volume":"54","author":"El-Tayeb","year":"2011","journal-title":"J. Med. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1586\/17512433.2015.1019343","article-title":"Leflunomide and Teriflunomide: Altering the Metabolism of Pyrimidines for the Treatment of Autoimmune Diseases","volume":"8","author":"Fragoso","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/jpet.108.136309","article-title":"UDP is a competitive antagonist at the human P2Y14 receptor","volume":"325","author":"Fricks","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.4049\/jimmunol.180.4.2659","article-title":"Intestinal inflammation increases the expression of the P2Y6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP","volume":"180","author":"Grbic","year":"2008","journal-title":"J. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/nature05704","article-title":"UDP Acting at P2Y6 Receptors Is a Mediator of Microglial Phagocytosis","volume":"446","author":"Koizumi","year":"2007","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.4049\/jimmunol.1000212","article-title":"Uridine 5'\u2010Diphosphate Induces Chemokine Expression in Microglia and Astrocytes Through Activation of the P2Y6 Receptor","volume":"186","author":"Kim","year":"2011","journal-title":"J. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.ai.2017.05.006","article-title":"P2Y receptors in immune response and inflammation","volume":"136","author":"Le Duc","year":"2017","journal-title":"Adv. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.4049\/jimmunol.1301930","article-title":"Extracellular UDP and P2Y6 Function as a Danger Signal to Protect Mice from Vesicular Stomatitis Virus Infection Through an Increase in IFN\u2010Beta Production","volume":"193","author":"Li","year":"2014","journal-title":"J. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.bcp.2004.01.011","article-title":"Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors","volume":"67","author":"Mamedova","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40265-013-0018-2","article-title":"Targeting interleukin-6 in rheumatoid arthritis","volume":"73","author":"Md Yusof","year":"2013","journal-title":"Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1002\/art.22929","article-title":"Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL","volume":"56","author":"Nagatani","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.alit.2017.02.014","article-title":"UDP\/P2Y6 receptor signaling regulates IgE-dependent degranulation in human basophils","volume":"66","author":"Nakano","year":"2017","journal-title":"Allergol. Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.4049\/jimmunol.167.9.5381","article-title":"Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"167","author":"Nanki","year":"2001","journal-title":"J. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","article-title":"The role and therapeutic targeting of IL-6 in rheumatoid arthritis","volume":"13","author":"Narazaki","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/glia.22693","article-title":"Inhibition of UDP\/P2Y 6 purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo","volume":"62","author":"Neher","year":"2014","journal-title":"Glia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bbrc.2008.03.119","article-title":"Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors","volume":"370","author":"Parandeh","year":"2008","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.4049\/jimmunol.1501629","article-title":"TLR-Activated Gap Junction Channels Protect Mice against Bacterial Infection through Extracellular UDP Release","volume":"196","author":"Qin","year":"2016","journal-title":"J. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.archoralbio.2011.05.003","article-title":"Pressure induces interleukin-6 expression via the P2Y6 receptor in human dental pulp cells","volume":"56","author":"Satrawaha","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"The Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41467-017-02659-x","article-title":"Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation","volume":"9","author":"Stephenson","year":"2018","journal-title":"Nat. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1164\/rccm.201011-1762OC","article-title":"Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation","volume":"184","author":"Vieira","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuropharm.2015.10.030","article-title":"Pharmacology and structure of P2Y receptors","volume":"104","author":"von K\u00fcgelgen","year":"2016","journal-title":"Neuropharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13075-019-2001-0","article-title":"Potential therapeutic effects of cyanidin-3-O-glucoside on rheumatoid arthritis by relieving inhibition of CD38+ NK cells on Treg cell differentiation","volume":"21","author":"Wang","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcb.24156","article-title":"Norisoboldine inhibits the production of interleukin-6 in fibroblast-like synoviocytes from adjuvant arthritis rats through PKC\/MAPK\/NF-\u03baB-p65\/CREB pathways","volume":"113","author":"Wei","year":"2012","journal-title":"J. Cel. Biochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e12654","DOI":"10.1111\/sji.12654","article-title":"Hypoxia induces production of citrullinated proteins in human fibroblast-like synoviocytes through regulating HIF1\u03b1","volume":"87","author":"Yu","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.4049\/jimmunol.1002946","article-title":"P2Y6Agonist uridine 5\u2032-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes\/macrophages recruitment","volume":"186","author":"Zhang","year":"2011","journal-title":"J Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.658511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:23:46Z","timestamp":1618791826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.658511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":34,"alternative-id":["10.3389\/fphar.2021.658511"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.658511","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-56879\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-56879\/v2","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"article-number":"658511"}}